4UHL | pdb_00004uhl

VFV: N-[(1R)-1-(3,4'-difluorobiphenyl-4-yl)-2-(1H-imidazol-1-yl)ethyl]-4-(5-phenyl-1,3,4-oxadiazol-2-yl)benzamide

VFV is a Ligand Of Interest in 4UHL designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4UHL_VFV_D_580	70%	24%	0.136	0.955	2	1.14	5	4	0	0	100%	1
4UHL_VFV_A_580	69%	25%	0.131	0.947	2	1.08	6	3	1	0	100%	1
4UHL_VFV_E_580	69%	22%	0.149	0.964	2.15	1.14	7	5	2	0	100%	1
4UHL_VFV_C_580	68%	24%	0.134	0.946	1.94	1.18	5	5	8	0	100%	1
4UHL_VFV_B_580	68%	26%	0.141	0.953	1.86	1.16	6	5	6	0	100%	1
4UHL_VFV_G_580	68%	25%	0.149	0.961	1.93	1.14	7	4	4	0	100%	1
4UHL_VFV_C_600	64%	14%	0.156	0.955	2.55	1.32	7	7	10	0	100%	1
4UHL_VFV_D_600	64%	19%	0.153	0.951	2.38	1.12	6	4	5	0	100%	1
4UHL_VFV_F_580	63%	23%	0.146	0.943	2.03	1.17	6	5	1	0	100%	1
4UHL_VFV_B_600	62%	19%	0.155	0.949	2.46	1.01	5	3	1	0	100%	1
4UHL_VFV_E_600	62%	19%	0.163	0.955	2.28	1.19	5	4	3	0	100%	1
4UHL_VFV_A_600	59%	14%	0.157	0.941	2.52	1.34	5	8	5	0	100%	1
4UHL_VFV_H_600	59%	13%	0.154	0.935	2.91	1.12	8	4	9	0	100%	1
4UHL_VFV_G_600	55%	16%	0.185	0.955	2.48	1.23	8	3	1	0	100%	1
4UHL_VFV_H_580	53%	25%	0.172	0.935	1.89	1.17	6	6	3	0	100%	1
4UHL_VFV_F_600	42%	14%	0.194	0.914	2.62	1.32	6	6	18	0	100%	1
4UHI_VFV_B_600	78%	30%	0.105	0.948	1.81	1.02	6	5	2	0	100%	1
4G7G_VFV_B_502	65%	8%	0.157	0.959	2.84	1.79	5	13	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.